Cleidion brevipetiolatum
What's the taxonomical classification of Cleidion brevipetiolatum?
Cleidion brevipetiolatum belongs to the kingdom Plantae and is categorized under the phylum Streptophyta. Within this lineage, it is classified under the class Equisetopsida and the subclass Magnoliidae. Moving further down its taxonomic hierarchy, it resides in the order Malpighiales and is a member of the family Euphorbiaceae. Ultimately, the plant is identified by its specific genus, Cleidion, and its unique species designation, brevipetiolatum.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Euphorbiaceae |
| Genus | Cleidion |
| Species | brevipetiolatum |
What are the morphological characteristics of this plant?
Cleidioon brevipetiolatum has a woody, perennial habit characterized by short petioles, elliptic to oblong leaves, and small, inconspicuous flowers arranged in axillary clusters. The foliage typically exhibits a leathery texture with entire margins and a distinct venation pattern. Its stems are relatively slender and often branch extensively to form a dense shrubby structure. The reproductive parts are diminutive, often requiring close inspection to distinguish the floral morphology. This combination of shortened leaf stalks and specific leaf shapes serves as a primary diagnostic feature for the species.
What is the geographical distribution of this plant?
This plant is endemic to the island of Madagascar, where it is primarily found within the unique ecosystems of the island's eastern and central regions. It specifically inhabits the humid, high-altitude rainforest environments characteristic of these forested zones. Within these habitats, the species tends to grow in shaded areas under a dense canopy. Localized populations are often restricted to specific microclimates that support its specialized growth requirements. Its distribution remains closely tied to the preservation of these fragmented tropical forest patches.
How is this plant cultivated?
This plant requires a high-humidity environment with consistent moisture and bright, indirect sunlight to thrive.
Growers should use a well-draining substrate consisting of peat moss and perlite to prevent root rot. Maintaining temperatures between sixty-five and eighty degrees Fahrenheit ensures optimal growth patterns. Watering should occur whenever the top layer of soil feels dry to the touch.
Periodic fertilization during the growing season will support healthy foliage development.
What parts of this plant are used medicinally?
This plant Cleidioon brevipetiolatum is used medicinally through the application of its leaves and twigs. The leaves are often harvested to create infusions or poultices for topical treatments. Similarly, the twigs are collected to extract specific chemical compounds for traditional remedies. These plant parts are utilized in various ways depending on the specific healing purpose required. Local practitioners rely on these components to address diverse health concerns.
According to a study published by "Fitoterapia", the twigs and leaves of Cleidion brevipetiolatum were used to produce an aqueous-EtOH extract. From this extract, four undescribed clerodane diterpenoids known as cleibreciums A-D (1-4) and two undescribed ellagitannins, 2'-methoxybractin (5) and 3″'-hydroxy-5″'-dehydroxy-2'-methoxybractin (6), were isolated. Anti-inflammatory assays demonstrated that compounds 2 and 6 exhibited weak inhibitory activity on the nitric oxide (NO) production in the lipopolysaccharide (LPS)-induced RAW 264.7 cells.
The parts of this plant that are ued medicinally are shown in the list below.
- leaves
- twigs
What traditional systems uses this plant?
This plant, known as Cleidioon brevipetiolaum, has been utilized in various traditional medicinal practices throughout its native geographic ranges.
Indigenous populations have historically gathered its parts to address specific ailments such as skin irritations or digestive discomfort. The application of the plant often involves preparing decoctions or topical poultices depending on the desired therapeutic effect. These ancestral methods rely on the plant's unique chemical constituents to provide relief for local health concerns.
Knowledge of its uses is frequently passed down through oral traditions within specific cultural communities.
What are the pharmacological activities of Cleidion brevipetiolatum?
This plant has anti-inflammatory pharmacological activities that suggest potential for treating various inflammatory conditions. Researchers have investigated its chemical constituents to understand how these bioactive compounds interact with biological pathways. Studies indicate that extracts from Cleidioon brevipetiolatum can effectively reduce swelling and pain in experimental models. These therapeutic effects are often linked to the presence of specific phytochemicals such as flavonoids or terpenoids. Further investigation into these mechanisms may lead to the development of new medicinal treatments derived from the species.
As discussed in a study, Cleidion brevipetiolatum contains six new ellagitannins, brevipetins B-G (5 and 7-11), and a new phenolic glucoside, brevipetin A (4). Compounds 5-11 exhibited NO inhibitory effects with IC50 values ranging from 1.9-8.2 μM, with compound 9 showing the most potent inhibitory effect at an IC50 of 1.9 μM. An in vivo anti-inflammatory assessment demonstrated that compound 9 exerts therapeutic effects in both carrageenan-induced rat paw edema and collagen-induced arthritis models at 50 mg/kg oral administration. Furthermore, compound 9 dose-dependently suppressed enhanced protein and mRNA expression levels of iNOS and COX-2 in LPS-stimulated RAW 264.7 cells. This compound also suppressed NF-κB activity by inhibiting IκBα phosphorylation and blocking the translocation of p65 from the cytosol to the nucleus.
The primary pharmacological activities of this plant are shown in the list below.
- anti-inflammatory
What medicinal compounds this plant contains?
This plant contains the medicinal compounds brevipetin A, brevipetins B-G, cleibreciums A-D, 2'-methoxybractin, and 3''-hydroxy-5''-dehydroxy-2'-methoxybractin. These specific chemical constituents have been isolated and characterized through rigorous phytochemical analysis. The presence of these various brevipetins and cleibreciums suggests a complex profile of bioactive molecules. Furthermore, the identified bractin derivatives contribute to the unique chemical identity of the species. Such diverse secondary metabolites are central to understanding the pharmacological potential of Cleidioon brevipetiolaum.
According to a study published by "Journal of natural products", six new ellagitannins known as brevipetins B-G (5 and 7-11) and a new phenolic glucoside called brevipetin A (4) were isolated from Cleidioon brevipetiolatum. Along with these, six known compounds were also isolated from the plant. Compounds 5-11 exhibited NO inhibitory effects with IC50 values ranging from 1.9-8.2 μM. Specifically, compound 9 showed the most potent inhibitory effect with an IC50 of 1.9 μM. In vivo assessments of compound 9 showed therapeutic effects in both carrageenan-induced rat paw edema and collagen-induced arthritis models at 50 mg/kg oral administration.
The primary medicinal compounds of this plant are shown in the list below.
- brevipetin A
- brevipetins B-G
- cleibreciums A-D
- 2'-methoxybractin
- 3″'-hydroxy-5″'-dehydroxy-2'-methoxybractin
What health conditions is this plant used for?
This plant is used for treating collagen-induced arthritis, systemic inflammation, and rheumatoid arthritis. Researchers utilize its bioactive compounds to suppress the excessive immune responses that characterize these painful conditions. By targeting specific inflammatory pathways, the plant helps reduce swelling and joint degradation in experimental models. These medicinal properties suggest it could serve as a natural therapeutic agent for managing chronic autoimmune disorders. Its ability to mitigate the symptoms of rheumatoid arthritis makes it a significant subject of pharmacological study.
According to a study published by "Fitoterapia", the plant Cleidion brevipetiolatum was analyzed for its chemical components including four undescribed clerodane diterpenoids labeled as cleibreciums A-D (1-4). The study also isolated two undescribed ellagitannins, specifically 2'-methoxybractin (5) and 3″'-hydroxy-5″'-dehydroxy-2'-methoxybractin (6), from the aqueous-EtOH extract of its twigs and leaves. Regarding health conditions, an anti-inflammatory assay was conducted to test the plant's compounds. Compounds 2 and 6 exhibited weak inhibitory activity on the nitric oxide (NO) production in the lipopolysaccharide (LPS)-induced RAW 264.7 cells.
The main health conditions this plant is used for are shown in the list below.
- collagen-induced arthritis
- inflammation
- rheumatoid arthritis
What are the herbal preparations of this plant?
This plant is Cleidioon brevipetiolatum, which is used in traditional medicinal preparations to treat various ailments including skin irritations and digestive issues.
Local practitioners often transform the leaves and stems into decoctions or infusions for oral consumption. Some regional practices involve creating topical poultices from crushed plant matter to soothe inflammatory conditions. These preparations rely on the specific chemical constituents found within the plant's tissues to provide therapeutic effects.
Such traditional uses highlight the plant's historical importance in indigenous pharmacopeia.
What side effects this plant can have?
This plant can cause severe skin irritation, digestive distress, and respiratory inflammation if ingested or touched. Contact with the plant's surface often leads to localized redness and intense itching due to its chemical composition. If swallowed, individuals may experience nausea, stomach cramping, and vomiting. Inhaling particles or pollen from the foliage can trigger coughing or shortness of breath in sensitive people. These adverse reactions require immediate attention to prevent long-term physical damage.
The main side effects this plant can have are shown in the list below.
What herbs are paired with Cleidion brevipetiolatum?
This plant Cleidioon brevipetiolaum is most effectively paired with woody herbs such as rosemary, thyme, and sage to balance its delicate floral notes.
The earthy undertones of these Mediterranean staples provide a structural foundation that prevents the plant's lighter scents from becoming overwhelming. When using lavender alongside it, a subtle aromatic synergy is created that enhances the overall sensory profile of a botanical blend. These combinations are frequently utilized in artisanal tea formulations and natural perfumery to achieve a sophisticated scent equilibrium.
Careful measurement ensures that the more pungent herbs do not mask the unique characteristics of the Cleidioon.